Home › Compare › RELIW vs MRK

RELIW vs MRK: Dividend Comparison 2026

RELIW yields 44444.44% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RELIW wins by $1.4802188700273396e+23M in total portfolio value
10 years
RELIW
RELIW
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full RELIW calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — RELIW vs MRK

📍 RELIW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRELIWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RELIW + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RELIW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RELIW
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, RELIW beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RELIW + MRK for your $10,000?

RELIW: 50%MRK: 50%
100% MRK50/50100% RELIW
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RELIW
No analyst data
Altman Z
-7.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RELIW buys
0
MRK buys
0
No recent congressional trades found for RELIW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRELIWMRK
Forward yield44444.44% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$1.4802188700273396e+23M$30.7K ✓
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00 ✓$950.29
Total dividends collected$1.4797905017086652e+23M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RELIW vs MRK ($10,000, DRIP)

YearRELIW PortfolioRELIW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$4,455,144$4,444,444.44$11,192$351.54+$4.44M → RELIW
2$1,855,294,292$1,850,527,287.41$12,524$392.70+$1855.28M → RELIW
3$722,201,114,647$720,215,949,754.98$14,015$438.65+$722201.10M → RELIW
4$262,786,638,114,837$262,013,882,922,164.10$15,682$489.96+$262786638.10M → RELIW
5$89,382,811,928,504,960$89,101,630,225,722,080.00$17,547$547.23+$89382811928.49M → RELIW
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$19,632$611.16+$28419510536946.59M → RELIW
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$21,963$682.53+$8446906587814894.00M → RELIW
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$24,571$762.18+$2346953255508951552.00M → RELIW
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$27,486$851.08+$609599312292179607552.00M → RELIW
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$30,745$950.29+$1.4802188700273396e+23M → RELIW

RELIW vs MRK: Complete Analysis 2026

RELIW — Stock

Reliance Global Group, Inc. engages in the acquisition and management of wholesale and retail insurance agencies in the United States. It provides healthcare and Medicare, personal and commercial, trucking and transportation, and employee benefits insurance products. The company was formerly known as Ethos Media Network, Inc. and changed its name to Reliance Global Group, Inc. in October 2018. Reliance Global Group, Inc. was incorporated in 2013 and is headquartered in Lakewood, New Jersey.

Full RELIW Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this RELIW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RELIW vs SCHDRELIW vs JEPIRELIW vs ORELIW vs KORELIW vs MAINRELIW vs JNJRELIW vs ABBVRELIW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.